John L. Higgins, Chief Executive Officer at LIGAND PHARMACEUTICALS INC (LGND), sold 2,000 shares at $90.00 ($180K) on 2022-09-15, disclosed to the SEC on 2022-09-16.
Open-market sale of $180k LGND by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| OABI | BUY | 2025-03-21 | $9K | — | Filing → |
| OABI | BUY | 2025-03-20 | $591K | — | Filing → |
| TECH | SELL | 2024-05-16 | $335K | — | Filing → |